Cord blood therapy for a child with eosinophilic duodenitis and autism
Treatments studied
Part of Blood & lymphatic, Digestive system, Immune system & allergy, Mental health clinical trials.
This study tests whether a child's own stored umbilical cord blood, given through an IV, can help with symptoms of eosinophilic duodenitis (a type of stomach inflammation) and autism spectrum disorder. It aims to see if this treatment is safe and possibly helpful for a 4-year-old child.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 4 years old when joining the study.
- Your child must have been diagnosed with both eosinophilic duodenitis and autism spectrum disorder.
- Your child must be receiving outpatient care at the Department of Rehabilitation Medicine at CHA Bundang Medical Center.
- Your child's own umbilical cord blood must be stored at an accredited cord blood bank.
- You (as parent or guardian) must give written permission after receiving a full explanation of the study.
- Your child cannot have severe uncontrolled medical conditions, severe allergies to the treatment components, or recent participation in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage study exploring a new experimental treatment for autism spectrum disorder (ASD). Researchers will work with your child and family to test whether this approach is safe and how it might help with autism symptoms.
This study tests a combination of experimental treatments for children with autism spectrum disorder. It may help if your child has not had stem cell or glutathione therapy before.
This study tests whether a combination of stem cell therapy, gut microbiome restoration (using specially prepared stool), and dietary changes can improve autism symptoms, communication, social behavior, and digestive issues. Researchers believe gut health and immune system problems may contribute to autism, and this trial explores whether treating these areas helps.
This trial tests whether fecal microbiota transplantation can help children with moderate-to-severe autism. It involves giving healthy donor bacteria to improve gut health and possibly autism symptoms.
This study tests whether transplanting healthy bacteria into the gut (called fecal microbiota transplantation) can improve digestive symptoms and autism-related behaviors in children. If your child has autism and ongoing digestive issues, this treatment may help.
This trial tests a new therapy that aims to help the brain grow new connections in children with autism. It uses a non-invasive device, so no surgery or drugs are involved, and it may help improve communication and daily skills.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.